Clinical Trials
4
Active:0
Completed:3
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)Reward-based Technology to Improve OUD Treatment
Not Applicable
Terminated
- Conditions
- Opioid Use Disorder
- First Posted Date
- 2022-01-06
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- Q2i, LLC
- Target Recruit Count
- 41
- Registration Number
- NCT05180669
- Locations
- 🇺🇸
UMass Chan Medical School, Worcester, Massachusetts, United States
Usability Testing for the Reward-based Technology to Improve OUD Treatment
Not Applicable
Completed
- Conditions
- Medication for Opioid-use DisorderOpioid-use DisorderContingency Management
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2023-05-30
- Lead Sponsor
- Q2i, LLC
- Target Recruit Count
- 26
- Registration Number
- NCT05159362
- Locations
- 🇺🇸
UMass Chan Medical School, Worcester, Massachusetts, United States
Technology for MAT in Primary Care - Phase 2
Not Applicable
Completed
- Conditions
- Opioid-use Disorder
- First Posted Date
- 2021-08-23
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Q2i, LLC
- Target Recruit Count
- 246
- Registration Number
- NCT05017272
- Locations
- 🇺🇸
UCLA Center for Behavioral and Addiction Medicine, Los Angeles, California, United States
Technology for MAT in Primary Care - Phase 1
Completed
- Conditions
- Opioid-use Disorder
- First Posted Date
- 2021-08-16
- Last Posted Date
- 2021-08-16
- Lead Sponsor
- Q2i, LLC
- Target Recruit Count
- 45
- Registration Number
- NCT05006846
- Locations
- 🇺🇸
UCLA Center for Behavioral and Addiction Medicine, Los Angeles, California, United States
News
No news found